Quick browse by jurisdictions
China is fast becoming an essential part of any
ambitious rights holder’s global strategy.
Following these 10 golden rules can help
businesses to protect their patents and get the
most from their inventions in China
The comprehensive healthcare bill recently
passed by the US Congress includes an
approval pathway for biosimilar biological
products. The regime for biosimilar products in
the United States is therefore set to change
The Waxman-Hatch Act offers opportunities to
manufacturers of both brand and generic drugs
in terms of market entry and exclusivity
periods. A canny and fluid litigation strategy
can help parties to take best advantage of the
provisions available
Earlier this year the Supreme Court issued
welcome clarification on how the Linkage
Regulation applies to formulation patents and
their publication in the Linkage Gazette
Strong IP protection is essential to the biotech
industry and Thailand has made innovative
strides in this field, including setting up the
region's first dedicated IP court. However,
other laws seek to protect natural resources
from “privatisation” by biotech companies
Supplementary protection certificates (SPCs)
are a valuable resource; however, the
regulatory regime for SPCs in Sweden and the
European Union is still evolving. Rights holders
should be aware of all the issues in order to
secure the best possible protection
New case law is moving patent practice
forward as courts and judges continue to be at
the forefront of interpreting the nation’s IP laws